A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization
about
beta-Amyloid degradation and Alzheimer's diseaseEndothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and beta-arrestinsOrganization and chromosomal localization of the human ECEL1 (XCE) gene encoding a zinc metallopeptidase involved in the nervous control of respirationEndothelinEndothelin-converting enzymes and related metalloproteases in Alzheimer's diseaseConstitutive phosphorylation of human endothelin-converting enzyme-1 isoformsHeterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloproteaseHighly sensitive and selective fluorescence assays for rapid screening of endothelin-converting enzyme inhibitorsEndothelin-converting enzyme 1 promotes re-sensitization of neurokinin 1 receptor-dependent neurogenic inflammationCharacterization of the c-specific promoter of the gene encoding human endothelin-converting enzyme-1 (ECE-1).Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents.Endothelins in chronic diabetic complications.Regulation of blood pressure and salt homeostasis by endothelin.The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injuryApplicability of green fluorescence protein in the study of endothelin converting enzyme-1c trafficking.Regulation of vascular contractility and blood pressure by the E2F2 transcription factor.Endothelin-converting enzyme-1 (ECE-1) is post-transcriptionally regulated by alternative polyadenylationTherapeutic potential of endothelin receptor modulators: lessons from human clinical trials.Physiology of endothelin and the kidney.Ambrisentan for the treatment of pulmonary arterial hypertensionAre amyloid-degrading enzymes viable therapeutic targets in Alzheimer's disease?Early progress in epigenetic regulation of endothelin pathway genes.The role of endothelin-1 in pulmonary arterial hypertension.An arterial-specific enhancer of the human endothelin converting enzyme 1 (ECE1) gene is synergistically activated by Sox17, FoxC2, and Etv2.Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression.Recent Advances in the Genetics of Hypertension.Herpesvirus saimiri-based endothelin-converting enzyme-1 shRNA expression decreases prostate cancer cell invasion and migration.ECE-1 influences prostate cancer cell invasion via ET-1-mediated FAK phosphorylation and ET-1-independent mechanisms.Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion.Endothelin-converting enzyme-1, abundance of isoforms a-d and identification of a novel alternatively spliced variant lacking a transmembrane domain.Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme.Protein Kinase C Regulates the Cell Surface Activity of Endothelin-Converting Enzyme-1Endothelin-1 and norepinephrine overflow from cardiac sympathetic nerve endings in myocardial ischemia.Pharmacological hypothesis: Nitric oxide-induced inhibition of ADAM-17 activity as well as vesicle release can in turn prevent the production of soluble endothelin-converting enzyme.Conserved cysteine and tryptophan residues of the endothelin-converting enzyme-1 CXAW motif are critical for protein maturation and enzyme activity.Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease.Association of endothelin-converting enzyme-1b C-338A polymorphism with increased risk of ischemic stroke in Chinese Han population.Expression of human endothelin-converting enzyme isoforms: role of angiotensin II.Histochemical distribution of endothelin-converting enzyme subtypes in Podarcis sicula (Squamata, Lacertidae) tissues.
P2860
Q21284467-866ADBB9-DA80-4F20-B3E7-1097B2ABEC7BQ24301478-DC061065-D19E-4D4F-AE43-402B6D238D67Q24531979-8A46E612-84C5-4529-B493-B5A1E987B1EAQ26767156-E7089C90-11B1-4C9C-86D1-B8C0CCB02298Q26862901-FF8D2514-13F8-472E-8699-988828267BE6Q28202978-38B65E6F-815B-425A-8BBF-8CD01565940FQ28209988-946FBC87-0B22-45BA-AC69-2ABA0C2F7535Q28366274-04781FBC-1FB2-4F2C-8999-EAE06EF8223BQ28583662-F2848395-5C01-4703-BBAD-81299348D8BAQ30840496-30609A27-563C-4E0B-AB26-3BF2B6AD9B5EQ34496108-E5BA42E7-45D1-477A-AD7D-77F616D507FBQ35168430-FF1DDF4B-1ABE-456C-9C5E-0DCCF01251EFQ35609851-CF6D9C86-738E-49CC-A5DC-73321958BCEBQ36510011-3ECF16A6-2CC4-49B2-8ECB-5B5346C8FE1AQ36595381-31CCAC1C-49D5-4C8D-AB3F-7353F15C9E9BQ36678266-EFA0D187-213F-4886-88C8-E9426AD1D3EDQ37445515-3D84C253-C579-4A15-B748-32F75004C448Q37537948-61EE93F0-5E38-49B7-8373-8BE9BB614D57Q37573815-941992EF-B187-497E-A849-3D9331899C0DQ37613679-04411945-C8DB-4F88-B2FF-C1EEC0F7C9F7Q37634323-63E5593D-ECF8-42F4-A02F-3E1E0D123237Q37961852-65A2036B-B8A9-4A0C-8A63-91A6F975F75FQ37973381-2FC0BCF6-AABE-4DCF-885B-66A91FF057A6Q38269052-E6EF628A-9E17-406B-90B9-5E9FE612F7A9Q38304524-56C57535-A52E-4E96-A56E-AF911414464AQ38798534-A18846F5-B8DB-4090-87CE-4A94D49433ADQ39037230-876938ED-0CAD-4B41-AD75-46F4C181E873Q39643724-270F22F9-4488-44B8-BC84-579921DBA4C7Q39665344-47A15371-0F82-41B5-88B7-6FD1F723CA01Q39941689-8966F971-417C-4487-B818-052A20D22464Q40368698-83045B9F-E915-4690-8318-A04B8939CC5FQ40808050-BD0EA10D-9DF4-45F7-8031-423BF2FF2322Q42093880-EEA79BDF-678C-49F4-9C3E-4E7583CB768FQ42113176-EF9B29A2-8632-4477-B5FD-137E42237911Q42285713-2536D256-03D6-4384-88BE-5500376B1795Q43633795-2550FA61-5381-4D52-A607-40889439CFE6Q45039002-249AFA30-A996-4B2E-A227-FF80DAEC9EDCQ46024936-2B5D8AD3-F5D5-4589-8578-2963A94B3083Q46564546-03D4CF04-D237-4153-93FF-43C394046093Q46726041-80A91FA4-944A-4484-B05C-9BB8E3F1F412
P2860
A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A fourth isoform of endothelin ...... r cloning and characterization
@ast
A fourth isoform of endothelin ...... r cloning and characterization
@en
A fourth isoform of endothelin ...... r cloning and characterization
@nl
type
label
A fourth isoform of endothelin ...... r cloning and characterization
@ast
A fourth isoform of endothelin ...... r cloning and characterization
@en
A fourth isoform of endothelin ...... r cloning and characterization
@nl
prefLabel
A fourth isoform of endothelin ...... r cloning and characterization
@ast
A fourth isoform of endothelin ...... r cloning and characterization
@en
A fourth isoform of endothelin ...... r cloning and characterization
@nl
P2093
P2860
P3181
P1433
P1476
A fourth isoform of endothelin ...... r cloning and characterization
@en
P2093
D Lepailleur-Enouf
J B Michel
O Valdenaire
P2860
P304
P3181
P356
10.1046/J.1432-1327.1999.00602.X
P407
P50
P577
1999-09-01T00:00:00Z